Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 242 | 306 | 187 | 0 |
| Operating Income | -242 | -306 | -187 | N/A |
| Other Income | -12 | -39 | -4 | 0 |
| Pre-tax Income | -254 | -345 | -191 | 0 |
| Net Income Continuous | -254 | -345 | -191 | N/A |
| Net Income | $-254 | $-345 | $-191 | $N/A |
| EPS Basic Total Ops | -0.90 | -1.22 | -0.68 | N/A |
| EPS Basic Continuous Ops | -0.90 | -1.22 | -0.67 | N/A |
| EPS Diluted Total Ops | -0.90 | -1.22 | -0.68 | N/A |
| EPS Diluted Continuous Ops | -0.90 | -1.22 | -0.67 | N/A |
| EBITDA(a) | $-240 | $-305 | $-186 | $N/A |